| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.44 | 0.005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |